CONSIDERATIONS TO KNOW ABOUT DEUCRAVACITINIB

Moderate or weak CYP3A4 Inhibitors: Keep an eye on serum potassium through drug initiation or dosage adjustment of possibly Kerendia or maybe the average or weak CYP3A4 inhibitor, and modify Kerendia dosage as ideal (seven.one)Don't have any live vaccines (immunizations) if you are remaining dealt with with deucravacitinib. Test with the health car